Evidence map›Paper›PMID 28475896›Full record

ArticleCell2017

The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity.

Alexander Rialdi, Judd Hultquist, David Jimenez-Morales, Zuleyma Peralta, Laura Campisi, Romain Fenouil, Natasha Moshkina, Zhen Zhen Wang, Brice Laffleur, Robyn M Kaake and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Three Modes of Viral Adaption by the Heart.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Respiratory viruses: New frontiers-a Keystone Symposia report.Annals of the New York Academy of Sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 1 country.

Alexander RialdiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Judd HultquistDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
David Jimenez-MoralesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
Zuleyma PeraltaDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Laura CampisiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Romain FenouilDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Natasha MoshkinaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Zhen Zhen WangDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Brice LaffleurDepartment of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Robyn M KaakeDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
Michael J McGregorDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
Kelsey HaasDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
Evangelos PefanisRegeneron Pharmaceuticals and Regeneron Genetics Center, Tarrytown, NY 10591, USA.
Randy A AlbrechtDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Lars PacheBurnham Institute for Medical Research, La Jolla, CA 92037, USA.
Sumit ChandaBurnham Institute for Medical Research, La Jolla, CA 92037, USA.
Joanna JenDepartment of Neurology, University of California, Los Angeles, CA 90095, USA.
Jordi OchandoPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Minji ByunPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Uttiya BasuDepartment of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Nevan KroganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158-2140, USA.
Harm van BakelDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA.
Ivan MarazziDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA. Electronic address: ivan.marazzi@mssm.edu.
Icahn School of Medicine at Mount Sinai · USUniversity of California, San Francisco · USColumbia University · USInstitute for Medical Research · USRegeneron (United States) · USUniversity of California, Los Angeles · US

Funding

Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALBRECHT, RANDY A. · 2013 to 2017
$26.0M
Role of ncRNA Surveillance Complex "RNA Exosome" in Class Switch Recombination and Somatic HypermutationR01AI099195 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Uttiya Basu · 2012 to 2026
$9.8M
Multi-level analysis of influenza virus polymerase and its role in pathogenesisR01AI113186 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN, VAN BAKEL, HARM · 2015 to 2019
$3.0M
Non-coding RNA engineers antibody diversityDP2OD008651 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BASU, UTTIYA · 2011 to 2011
$2.4M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
SETX, antiviral response and genetic diseasesR56AI114770 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN · 2015 to 2015
$421k
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI099195NIAID NIH HHS R01 AI113186NIAID NIH HHS R56 AI114770NIAID NIH HHS U19 AI106754NIH HHS DP2 OD008651NIH HHS S10 OD018522
6 · The paper itself

Abstract

The nuclear RNA exosome is an essential multi-subunit complex that controls RNA homeostasis. Congenital mutations in RNA exosome genes are associated with neurodegenerative diseases. Little is known about the role of the RNA exosome in the cellular response to pathogens. Here, using NGS and human and mouse genetics, we show that influenza A virus (IAV) ribogenesis and growth are suppressed by impaired RNA exosome activity. Mechanistically, the nuclear RNA exosome coordinates the initial steps of viral transcription with RNAPII at host promoters. The viral polymerase complex co-opts the nuclear RNA exosome complex and cellular RNAs en route to 3' end degradation. Exosome deficiency uncouples chromatin targeting of the viral polymerase complex and the formation of cellular:viral RNA hybrids, which are essential RNA intermediates that license transcription of antisense genomic viral RNAs. Our results suggest that evolutionary arms races have shaped the cellular RNA quality control machinery.

Indexed as

Host-Pathogen InteractionsA549 CellsAnimalsChromatin ImmunoprecipitationExoribonucleasesExosome Multienzyme Ribonuclease ComplexExosomesHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanMass SpectrometryMiceMutationNeurodegenerative DiseasesRibosomesExoribonucleasesEXOSC10 protein, humanEXOSC3 protein, humanExosome Multienzyme Ribonuclease ComplexRNA-Binding ProteinsRNA Polymerase IIepigeneticshost-pathogen interactionsInfluenza virus polymeraseneurodegenerationnon-coding RNARNA chimerasRNA exosomeRNA hybridsRNAPII elongationRNA surveillance

Identifiers

PMID28475896
PMCPMC6217988
OpenAlexW2611318506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.